Skip to content

A study to evaluate the safety and effectiveness of a Hair care product

To evaluate the in vivo efficacy and safety of hair care formulation in terms of reduction in hair fall on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107189
Enrollment
36
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: GREEN APPLE Shampoo: Product is applied on Whole Head (Including Scalp and Hair shaft)three times in a week for the period of 28 days Control Intervention1: Nil: NA

Sponsors

Bio Veda Farmacy Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian male & female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having different hair types and mild to moderate hair fall.

Exclusion criteria

Exclusion criteria: 1 For female:- Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5 Having a progressive asthma (either under treatment or last fit in the last 2 years) 6 Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8 Being epileptic. 9 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10 Having cutaneous hypersensitivity. 11 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12 Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in hair fallTimepoint: Baseline, Day 14, Day 28

Secondary

MeasureTime frame
scalp conditioningTimepoint: Baseline, Day 14, Day 28

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026